A Maryland federal district judge has denied four separate drug industry attempts to block the state’s contract pharmacy access law—marking [...] …
Category: Pharma Industry
The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...] …
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...] …
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] …
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...] …
Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...] …
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...] …
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...] …